MSDC-0602K

Company with NASH Candidate in Ph IIb Trials Updates $86 Million IPO filing
CP Wire
Thu, 02/14/19 - 09:40 am
Cirius Therapeutics
NASH
MSDC-0602K
IPOs
Company with NASH Candidate in Ph IIb Trials Updates $86 Million IPO filing
Thu, 02/14/19 - 09:38 am
Cirius Therapeutics
NASH
MSDC-0602K
Cirius Therapeutics Completes Enrollment in Phase 2b EMMINENCE Trial in NASH
CP Wire
Wed, 05/2/18 - 07:12 pm
Cirius Therapeutics
NASH
MSDC-0602K
Cirius Therapeutics Completes Enrollment in Phase 2b EMMINENCE Trial in NASH
Wed, 05/2/18 - 09:22 am
Cirius Therapeutics
NASH
MSDC-0602K